Connect
← Return to Treatment Center Options - Aggressive Prostate Cancer
Discussion
Treatment Center Options - Aggressive Prostate Cancer
Prostate Cancer | Last Active: Oct 3 1:12pm | Replies (25)Comment receiving replies
@jeffmarc I am approx approx 5 months dx with prostate cancer gleason 7 3+4 and 1 biopsy 4+3 woth cribiform glands. After doing my own thorough research was able to get in a trial at Memorial Sloan Kettering for a monoclonal antibody treatment started 9/23 along with ADT started 9/2 . So far so good. Monoclonals are the way to go when it cones to killing cancer.
Replies to "@jeffmarc I am approx approx 5 months dx with prostate cancer gleason 7 3+4 and 1..."
For some reason, I missed the word “trial” and I’m wondering, which one you are involved in.
Are you referring to the trial with 2141-V11 an immune-activating CD40-targeting antibody, for high-risk localized disease. Mentioned by @dailyeffort
Or another study they are doing is with the PSMA targeting antibody MLN2704.
Is the one you are involved with even different from those?
Is it possible you could get a placebo in this trial, That’s one reason I’ve avoided trials, and fortunately, I have not needed one yet
Connect
@richiec
Are you referring to Provenge? That’s really the only Monoclonal antibody Available for prostate cancer itself, Unless you are involved in a clinical study. When you have Proveng it does not lower your PSA. It’s something you should have when your PSA is low and it will hopefully prevent the cancer from getting worse. Unfortunately it isn’t such a panacea.
Provenge extends survival for men with advanced, asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC), with an average survival benefit of 4.1 months in clinical trials compared to placebo.